Glucose Regulates Microtubule Disassembly and the Dose of Insulin Secretion via Tau Phosphorylation
Open Access
- 15 June 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 69 (9), 1936-1947
- https://doi.org/10.2337/db19-1186
Abstract
The microtubule cytoskeleton of pancreatic islet β-cells regulates glucose-stimulated insulin secretion (GSIS). We have reported that the microtubule-mediated movement of insulin vesicles away from the plasma membrane limits insulin secretion. High glucose–induced remodeling of microtubule network facilitates robust GSIS. This remodeling involves disassembly of old microtubules and nucleation of new microtubules. Here, we examine the mechanisms whereby glucose stimulation decreases microtubule lifetimes in β-cells. Using real-time imaging of photoconverted microtubules, we demonstrate that high levels of glucose induce rapid microtubule disassembly preferentially in the periphery of individual β-cells, and this process is mediated by the phosphorylation of microtubule-associated protein tau. Specifically, high glucose induces tau hyper-phosphorylation via glucose-responsive kinases GSK3, PKA, PKC, and CDK5. This causes dissociation of tau from and subsequent destabilization of microtubules. Consequently, tau knockdown in mouse islet β-cells facilitates microtubule turnover, causing increased basal insulin secretion, depleting insulin vesicles from the cytoplasm, and impairing GSIS. More importantly, tau knockdown uncouples microtubule destabilization from glucose stimulation. These findings suggest that tau suppresses peripheral microtubules turning over to restrict insulin oversecretion in basal conditions and preserve the insulin pool that can be released following stimulation; high glucose promotes tau phosphorylation to enhance microtubule disassembly to acutely enhance GSIS.Keywords
Funding Information
- Eli Lilly and Company (0101420)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK106228, DK065949, R35-GM127098, R01-GM078373)
This publication has 50 references indexed in Scilit:
- Targeted Inactivation of Kinesin-1 in Pancreatic β-Cells In Vivo Leads to Insulin Secretory DeficiencyDiabetes, 2010
- Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in miceDiabetologia, 2010
- Gαo Represses Insulin Secretion by Reducing Vesicular Docking in Pancreatic β-CellsDiabetes, 2010
- Glycogen synthase kinase 3β mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1Journal of Endocrinology, 2010
- Mechanisms of biphasic insulin-granule exocytosis – roles of the cytoskeleton, small GTPases and SNARE proteinsJournal of Cell Science, 2009
- Differential Regulation of Dynein and Kinesin Motor Proteins by TauScience, 2008
- Tau Becomes a More Favorable Substrate for GSK-3 When It Is Prephosphorylated by PKA in Rat BrainOnline Journal of Public Health Informatics, 2004
- Kinesin I and cytoplasmic dynein orchestrate glucose-stimulated insulin-containing vesicle movements in clonal MIN6 β-cellsBiochemical and Biophysical Research Communications, 2003
- How calcium causes microtubule depolymerizationCell Motility, 1997
- Microtubules and beta cell function: effect of colchicine on microtubules and insulin secretion in vitro by mouse beta cells.The Journal of cell biology, 1982